Table 1.
Survey demographics, percentage of participants willing to receive a COVID-19 vaccine or to recommend it to vulnerable friends/family and country-level pandemic indicators
| Country | Source | Date | N | MAge (SD) | Woman (%) |
Tertiary educated (%) |
Vaccine acceptance (%) | Vaccine recommend (%) | Total deaths | Days since first case | Cases week prior | Stringency Index |
| Australia | Dynata | 20 Mar | 700 | 46.3 (16.4) | 51.0 | 43.4 | 82.9 | 88.7 | 7 | 55 | 591 | 47.22 |
| China* | Respondi | 09 Apr | 700 | 43.2 (14.3) | 48.9 | 73.1 | 85.8 | 87.4 | 3335 | 144 | 276 | 56.94 |
| Germany | Respondi | 23 Mar | 700 | 46.7 (15.9) | 49.9 | 32.7 | 80.8 | 89.2 | 123 | 56 | 21 784 | 76.85 |
| Spain | Respondi | 22 Mar | 700 | 46.7 (15.0) | 51.1 | 58.1 | 83.6 | 89.8 | 1772 | 51 | 20 970 | 71.76 |
| Spain | Respondi | 06 May | 700 | 46.0 (15.0) | 50.4 | 57.0 | 79.8 | 82.5 | 25 857 | 96 | 7408 | 81.94 |
| France | BVA | 03 Apr | 3002 | 48.8 (16.5) | 52.5 | 71.1 | 69.7 | 80.7 | 6496 | 98 | 30 979 | 87.96 |
| Italy | Respondi | 22 Mar | 700 | 45.9 (14.8) | 50.4 | 41.3 | 85.3 | 88.2 | 5476 | 51 | 34 391 | 91.67 |
| Japan | Respondi | 10 Apr | 699 | 48.1 (16.4) | 50.9 | 53.3 | 74.5 | 80.1 | 125 | 85 | 3096 | 45.37 |
| South Korea | Respondi | 09 Apr | 700 | 45.3 (15.5) | 49.0 | 70.5 | 85.6 | 88.4 | 204 | 80 | 447 | 82.41 |
| Mexico | Respondi | 21 Mar | 693 | 38.7 (14.0) | 50.5 | 66.4 | 88.1 | 90.3 | 2 | 22 | 210 | 8.33 |
| Mexico | Respondi | 06 May | 700 | 38.6 (14.2) | 51.0 | 75.8 | 73.9 | 75.6 | 2704 | 68 | 9835 | 82.41 |
| Sweden | Respondi | 28 Mar | 700 | 45.5 (16.0) | 49.1 | 40.3 | 66.3 | 77.2 | 239 | 57 | 1795 | 50.93 |
| Sweden | Respondi | 17 Apr | 700 | 45.5 (16.5) | 48.9 | 40.2 | 63.4 | 73.7 | 1925 | 77 | 3690 | 64.81 |
| UK | Prolific | 19 Mar | 703 | 45.6 (15.7) | 50.9 | 53.9 | 80.4 | 91.7 | 162 | 48 | 4719 | 31.48 |
| UK | Prolific | 07 May | 1157 | 44.7 (15.7) | 50.7 | 56.5 | 80.4 | 86.7 | 30 321 | 97 | 25 582 | 79.63 |
| UK | Prolific | 06 Jul | 1325 | 44.5 (15.6) | 52.5 | 58.5 | 78.9 | 85.3 | 40 643 | 157 | 2461 | 64.35 |
| UK | Prolific | 18 Sep | 1869 | 38.2 (15.0) | 51.2 | 56.2 | 73.0 | 79.5 | 41 732 | 231 | 24 259 | 65.74 |
| UK | Respondi | 07 May | 1150 | 45.7 (15.9) | 52.0 | 43.4 | 78.9 | 84.2 | 30 321 | 97 | 25 582 | 79.63 |
| UK* | Respondi | 08 Jun | 500 | 45.9 (15.9) | 53.2 | 39.7 | 79.0 | 83.2 | 38 666 | 129 | 7742 | 73.15 |
| UK | Respondi | 06 Jul | 1326 | 45.4 (16.6) | 51.7 | 44.9 | 80.1 | 84.4 | 40 643 | 157 | 2461 | 64.35 |
| UK | Respondi | 18 Sep | 1855 | 45.5 (16.1) | 51.6 | 42.6 | 75.7 | 79.9 | 41 732 | 231 | 24 259 | 65.74 |
| UK | Respondi | 29 Oct | 1744 | 46.7 (16.0) | 52.2 | 42.0 | 72.2 | 76.1 | 45 955 | 272 | 154 873 | 75.00 |
| USA | Prolific | 19 Mar | 702 | 45.1 (15.8) | 50.6 | 66.8 | 75.7 | 85.7 | 264 | 58 | 12 077 | 67.13 |
| US | Respondi | 07 May | 700 | 45.0 (16.1) | 51.0 | 59.3 | 74.7 | 80.1 | 78 618 | 107 | 187 115 | 72.69 |
| US* | Respondi | 28 Sep | 909 | 44.8 (15.6) | 50.6 | 50.1 | 62.6 | 67.5 | 205 612 | 251 | 288 759 | 62.50 |
*Indicates survey that included vaccine acceptance items but not all model predictor variables (excluded from analyses below).